CB3 Pilot (Communication Bridge: A Person-centered Internet-based Intervention for Individuals With Primary Progressive Aphasia) (CB3 Pilot)
Aphasia, Primary Progressive Aphasia, Dementia
About this trial
This is an interventional treatment trial for Aphasia
Eligibility Criteria
Inclusion Criteria (person with PPA): Meets diagnostic criteria for PPA based on neurologist and supporting medical assessments (extracted from medical records) English as primary language used in daily communication activities (by self-report) Adequate hearing (aided or unaided) for communicating with others in a crowded room (by self-report) Adequate vision (aided or unaided) for reading a newspaper, or other functional materials (by self-report) Able to pass technology screening and demonstrates sufficient knowledge for use of video conference and Communication Bridge™ web application use (with or without training) Exclusion Criteria: A dementia diagnosis other than Primary Progressive Aphasia Participation is co-enrolled in an outside speech language therapy program during the study course. Communication partners will be excluded if they have a pre-existing communication impairment that would affect study participation (e.g., aphasia, dementia) Medical records may be requested and reviewed to determine eligibility.
Sites / Locations
- Mesulam Center for Cognitive Neurology & Alzheimer's Disease
Arms of the Study
Arm 1
Experimental
Experimental: Communication Bridge™
Participants receive Communication Bridge™, a multi-component, participation-focused, dyadic intervention in which both the person with PPA and their co-enrolled communication partner are intervention recipients. Communication Bridge™ is modelled on the Living with Aphasia: Framework for Outcome Measurement (A-FROM) and the Care Pathway Model that was developed for persons living with primary progressive aphasia. Consistent with participation-focused intervention models personally salient training stimuli are incorporated into all therapy activities in the Experimental arm.